Mental Health

Stopping the over-medication of children and young people with a learning disability, autism or both (STOMP) and supporting treatment and appropriate medication in paediatrics (STAMP). This [...]

Cariprazine (Reagila) is a new second-generation antipsychotic which is licensed to treat schizophrenia in adults (over 18 years). It is only available as an oral capsule and is presented in [...]

Public Health England has produced a suicide prevention profile in order to help develop understanding at a local level and support an intelligence-driven approach to suicide prevention. It [...]

I spent the two first weeks of October 2018 volunteering with a Basque NGO called Salvamento Marítimo Humanitario (SMH) – a humanitarian rescue association in the Greek island of Chios, [...]

This medicines evidence commentary document was published in February 2019 and covers the incidence, management and risk of suicide in over 65s with a history of self-harm. A UK study found that [...]

We have just launched a new addition to our Clinical Training Seminar Programme. The high dose antipsychotic treatment (HDAT) seminar discusses the rationale for high dose antipsychotic use, [...]

In December 2018, the Royal College of Psychiatrists published its position statement on the prescription of valproate-containing medicines to girls and women of reproductive potential, entitled [...]

This NICE guideline was published in December 2018 and covers recognising, assessing and treating post-traumatic stress disorder (PTSD). It aims to improve quality of life by reducing symptoms of [...]

This NICE quality standard was published in September 2018 and covers the assessment, treatment, monitoring and care for children, young people and adults with an eating disorder. It describes [...]

This NICE guideline was published in October 2018 and aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so. It also [...]